Elizabeth Franzmann, MD
Otolaryngology · Miami, FLNPI 1609894872
Payments from drug & device makers
Across 37 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$226
- Johnson & Johnson$162
- Eisai Inc.$101
- AstraZeneca$64
- Immunocore Limited$56
- Servier Pharmaceuticals LLC$50
- plus $293 from 14 others
What the payments were for
- Food & beverage$951100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 1 | $226 |
| Johnson & Johnson | 8 | $162 |
| Eisai Inc. | 5 | $101 |
| AstraZeneca(2 entities) | 3 | $64 |
| Immunocore Limited | 2 | $56 |
| Servier Pharmaceuticals LLC | 2 | $50 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Merck | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Beone Medicines USA, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $18 |
| Pharmaand GmbH | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Coherus Oncology, Inc. | 1 | $14 |
How this compares
$951 in reported general payments places this provider in the 35th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 11 | $555 |
| Fluconazole | 32 | $465 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $331 |
| Fluticasone Propionate | 26 | $322 |
| Nystatin | 11 | $250 |
| Chlorhexidine Gluconate | 19 | $95 |
| Omeprazole | 12 | $86 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $53 |
| Levothyroxine Sodium | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Miami
- Adrien EshraghiMiami$2.1M
- Maria SuurnaMiami$456K
- Corinna LevineMiami$112K
- Agustin ArrietaMiami$95K
- Abraham JaguanMiami$74K
- Francisco PernasMiami$70K
- Michael HofferMiami$32K
- Andres OrjuelaMiami$30K
- Roy CasianoMiami$26K
- Jason LeibowitzMiami$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.